New paradigm for drug therapies of cardiac fibrillation.
Karma
A
A
Department of Physics and Center for Interdisciplinary Research on Complex Systems, Northeastern University, Boston, MA 02115, USA.
D000200:Action Potentials / Q000187:drug effects; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000503:physiopathology; D003198:Computer Simulation; D015195:Drug Design; D004554:Electric Countershock; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008959:Models, Neurological; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D014693:Ventricular Fibrillation / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy
D000889:Anti-Arrhythmia Agents